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This study examined the timelines of the expedited ethics review process at the University of 
KwaZulu-Natal Biomedical Research Ethics Committee. The purpose of the study was to evaluate 
timeframes of BREC review processes for expedited ethics applications and identify specific phases 
in the review process associated with delays in the time taken to obtain ethical clearance. 
 
Method 
A sample of 200 cases of research proposals submitted to BREC for expedited review in two 
consecutive years, 2013 and 2014, were reviewed. The researcher drew 100 cases from 2013 and 
100 cases from 2014. The research took every third referenced expedited review application in the 
year 2013 and 2014 until the sample of 200 cases was reached. 
 
Results 
There were noticeable delays in the BREC review process, mainly from the applicants. The 
descriptive statistics show that it took a mean of 24.22 days and a median of 18.00 days for reviewers 
to respond to applicants. It took a mean and mode of 65.66 and 14.00 days, respectively, for 
applicants to respond to reviewers. These were the longest phases of the UKZN/BREC expedited 




The study showed that the BREC expedited review process had a slow turnaround time of 140 
days. The phase that contributed most to delays was the time it took applicants to respond to 
queries.  This phase is not under the control of BREC.  
 
Recommendations 
This data highlights the slowest elements of the ethics review process. Researchers and the 
UKZN/BREC should identify why these are the slowest phases and make efforts to improve these 
data in a future follow-up audit of these timelines. A forthcoming electronic document 
iii 
 
management system might also assist, and hopefully future data will show improvements in the 
slowest phases illuminated by the current study. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Introduction 
Ethics review is progressively becoming mandatory for social science and health science research. 
Ethics review is increasingly accepted as adding value to how studies are conducted in that they 
are required to address issues like protecting the rights of participants, safeguarding researchers 
from unwanted costs, and fairness. To comply with the South African Department of Health’s 
Research Ethics Guidelines of 2015, the majority of South African universities and research 
institutions require that an independent research ethics committee reviews all health and social 
science research that involves human participants prior to collection of data (Mamotte & 
Wassenaar, 2009). 
 
1.2 Rationale of the study 
Scholars have complained that ethics review processes delay research unnecessarily (Warlow, 
2005). This study, therefore, intends to review and evaluate the expedited ethics review process 
timeline at the University of KwaZulu-Natal’s Biomedical Research Ethics Committee (BREC). 
Such a study has the potential to assist in revising the current ethical review procedures adopted 
by BREC at the University of KwaZulu-Natal. The interest for such a study is further motivated 
by complaints students usually have for the delays in their ethical clearance. This research project 
is intended to help identify areas of potential delay in the process and to highlight possible ways 
to circumvent and reduce these delays. 
 
1.3 Objectives 
The objectives of this study are:   
a). To evaluate current timeframes of BREC review processes for expedited ethics applications. 
b). To identify specific phases in the review process associated with delays in the time taken to 
obtain ethics clearance. 






1.4 Research questions  
a). What are the modal, mean and median times taken for BREC review of expedited applications? 
b). Which phase of the review process takes the longest? 
 
1.5 Definition of terms 
Expedited: means review by the REC chair and one or more experienced reviewers, rather than 
review by a scheduled meeting of the research ethics committee. 
Expedited Ethics Review Process: “research may qualify for expedited review if it is judged to 
involve only minimal risk, does not include intentional deception, does not employ sensitive 
populations or topics, and includes appropriate informed consent procedures. For example, the 
collection of physical data through non-invasive procedures is eligible for an expedited review, 
including: Height and weight, ECG, MRI and Ultrasound, Moderate exercise, Blood or other 
bodily fluids” (45 CFR 46. 110). 
Minimal Risk: “the prospect and magnitude of harm or discomfort anticipated in the research are 
not greater than those ordinarily encountered in daily life or during the performance of routine 
physical or psychological examinations or tests” (45 CFR 46. 102). 
Phases: the time taken to progress from each stage of the review process.  
Research: a class of activity designed to develop or contribute to generalizable knowledge. 
Taxonomy: the practice and science of classification of things or concepts, including the 
principles that prompt such classification. 
Timeline: the time taken to complete the expedited ethics review process. 
Vulnerability: a significant incapability  to protect your own interests due to  barriers such as lack 
of capability to give informed consent, privation of means to obtain medical care or other exclusive 
needs, or being a junior or subordinate member of a hierarchical group. Accordingly, exceptional 
backing is necessary to protect welfare and rights of vulnerable persons (CIOMS, 2016). 
 
1.6 Delimitation and scope of the study 
The study examined the timelines in the expedited ethics review process at the University of 
KwaZulu-Natal, Biomedical Research Ethics Committee (UKZN/BREC). This study is therefore 




1.7 The scope of REC 
“The National Health Act, 2003 (Act No. 61 of 2003), proposes that the functions of research 
ethics committees will include: Reviewing research proposals and protocols to ensure that research 
will be conducted in the spirit of endeavouring to promote health, and to prevent or cure disability 
and disease; ensuring that humans involved in research are treated with dignity and that their well-
being is not compromised, and that animals involved in research are treated compassionately; 
Ensuring that informed consent is obtained in the case of human participants; granting approval in 
instances where research proposals and protocols meet ethical standards”. 
 
1.8. The scope of UKZN/BREC 
“The Biomedical Research Ethics Committee (hereafter referred to as "BREC") (international 
equivalent titles: Institutional Review Board (IRB), Independent Ethics Committee) is mandated 
to fulfil its function by the Senate of the University of KwaZulu-Natal through the University 
Research and Ethics Committee, to which BREC will report annually in writing” Source: 
(http://research.ukzn.ac.za/Research-Ethics/Biomedical-Research-Ethics.aspx). The essential 
purpose of BREC is to protect the dignity, rights, safety, and well-being of all human participants 
in health-related research. BREC will do this through independent, prospective and ongoing ethics 
review of all health research projects undertaken by members of staff, registered students and 
affiliates of the University. Special attention will be paid to research that may include vulnerable 
participants. The Committee is available to review, advise on, and approve or reject research 
protocols involving human participants submitted to it by researchers at UKZN and, at the 
discretion of the Chair, in the province of KwaZulu-Natal or any other province in the Republic of 
South Africa who are not UKZN staff members, students or affiliates. Research to be reviewed 
will be in accordance with the provisions of the National Health Act. In addition, when the 
University undertakes non-exempt human participant research that is supported by the US 
Department of Health and Human Services (HHS), the University and BREC will ensure that the 
HHS protection of human participants’ regulations are adhered to (UKZN/BREC ToR & SOPs, 






   CHAPTER 2: LITERATURE REVIEW 
 
2.1 Introduction 
A requirement of conducting health and social science that involves human participants in South 
African universities and research institutions, is that before data collection can take place, an 
independent research ethics committee (REC) reviews the proposed research (Mamotte & 
Wassenaar, 2009).  
 
2.2 Ethics review processes 
The bureaucratization of processes of ethics approval of research has meant that delays and 
expenses in doing research are prominent (Clarke, 2012). In South Africa, research with human 
participants has to be authorized by a registered research ethics committee (REC) before data 
collection can begin (Mamotte & Wassenaar, 2009). This is a universal requirement for 
researchers. In the United States, the governing federal regulation, 45 CFR 46, maintains that only 
human participants research that is federally funded should get IRB approval (Howe & Dougherty, 
1993). However, in practice most US universities require IRB approval for all human subjects 
studies (Howe & Dougherty, 1993).  
 
The South African National Health Act of 2003 requires that a NHREC-registered REC reviews 
all health-related research, including social and behavioural research that is done in South Africa. 
Furthermore, it should adhere to the provisions of the South African research ethics guidelines 
(DoH, 2015). Clinical trials must also comply with the South African guidelines on good clinical 
practice (GCP), 2006). According to UKZN/BREC’s standard operating procedures (SOP) 
(http://research.ukzn.ac.za/Research-Ethics/Biomedical-Research-Ethics.aspx), studies differ in 
the ethical review processes they must undergo; some studies obtain expedited ethical review and 
others have to undergo a full ethics review, depending on their levels of risk.   
 
A study conducted by Clarke (2012) reviewed the ethics approval process of Master of Medicine 
(MMed) degrees (mostly by expedited ethics review) at UKZN to ascertain whether the process of 
obtaining ethics approval was functioning optimally and to detect areas where it may be improved. 
In his study, he found that “a total of 53 proposals for MMed degrees for the year 2010 were 
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obtainable for study” (Clarke, 2012, p. 24) These proposals included varieties of studies such as: 
“retrospective chart audit (29), prospective audit (14), questionnaire (9), cross-sectional study (1), 
randomised interventional study (nil), and cadaver based anatomical study (1)” (Clarke, 2012, p. 
24). According to Clarke’s (2012, p. 24) analysis, “BREC took an average of 14.8 weeks (103 
days) to approve to each of the 53 protocols (range 3-32 weeks). Of these, 21 (39%) received 
provisional approval in the first reaction”. For about 56% required major amendments and two 
were rejected. Clarke’s (2012) findings can, however, be critiqued in that he did not calculate or 
take into consideration the mode, to enable a reader to judge how often these incidents occurred. 
However, his conclusion was that obtaining ethics approval for a MMed study was a lengthy 
process. He also reported that concerns about scientific validity was the most frequent cause of 
queries. 
 
Other related studies have also asserted that getting ethics approval takes more time than expected. 
Other REC chairs do not grant approval for studies that are approved somewhere else without a 
full submission made for local correspondence. Specifically for multi-center studies, overall one-
third of RECs, as asserted by Ahmed and Nicholson (1996), were unable to approve the project 
within three months, and three of the 36 (8%) took longer than six months. These delays in 
obtaining approval were evidently linked to the regularity with which ethics committees met, and 
their workload. Although these data were reported 21 years ago, it suggests that obtaining ethics 
approval has always been difficult and time consuming.    
 
A study conducted by Mamotte and Wassenaar (2009) showed that the same problems and 
frustrations that are faced by developed countries’ researchers are also faced by South African 
researchers. However, empirical evidence collected in various published studies showed that IRBs 
in the US differ in the way they apply federal regulations, their review turnaround time, and in the 
decisions they make (Abbott & Grady 2011).  Mamotte and Wassenaar (2009) found that ethics 
review issues in South Africa are not due to the underdevelopment of the country, but are due to 
common review practices inevitably arising in institutions. South Africa and all other developing 
countries have the advantage of learning from developed countries’ frustrations and blunders, so 
they can custom their own review processes in standards that are more strategic to crucial ethical 
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issues that arise in research and avoid procedures that have delayed developed countries’ ethics 
review processes. 
 
It is further noticeable that very few ethics applications are approved at the first review. In  review 
of 1 180 protocols to the HREC (Medical) of the University of the Witwatersrand (Wits) in 2003 
and in 2007, 21% of the protocols received approval on the first reaction of HREC, 72% needed 
slight or considerable amendments, HREC did not approve 5% of these protocols, and 2% were 
withdrawn, (Cleaton-Jones, 2010). Angell and Dixon-Woods (2009) reported on a review of 141 
letters written by UK National Health Service RECs in a period of four months. The decision 
percentages were: 15% for approved, 64% for amendments, 8% for not approved, and 13% for 
withdrawn, percentages just about comparable to those at Wits University. 
 
Researchers often complain that the REC’s review process is incompetent and research ends up 
being delayed for what seem to be insignificant concerns (Whitney, Kemper, Bauman, Rosene, & 
Blatt, 2008). Literature further reveals that strain and objections to the REC’s approval processes 
at times results in sites and researchers being hesitant to take part in research (Mansbach, 
Acholonu, Clark, & Camargo, 2007). On the other hand, the public learns about problems 
surrounding the process of conducting research and fears that research is perhaps perilous and 
maybe the provisions made to protect them (participants) are not efficient (Lemonick, Goldstein 
& Park, 2002, cited in Abbott & Grady, 2011). In this sense therefore, research ethics committees 
(RECs) encounter various complications while attempting to achieve their goal of ensuring 
protection of research participants (Abdel-Aal, Ghafar & El Shabawy, 2013).  
 
Silaigwana and Wassenaar, 2016 conducted a collective review of empirical studies examining the 
structure, functioning, and review outcomes of African RECs to describe what is known in these 
areas and to identify gaps in the knowledge about RECs. Their review showed that the functioning 
of RECs was undermined by inadequate financial resources, inadequate training of members and 
few resources to review and monitor studies within an acceptable timeframe. Their interpretation 
of these results was that “while some RECs have well-established structural and functional status, 
additional financial support and training would be beneficial to enhance the capacity of African 
RECs” (Silaigwana and Wassenaar, 2016, p. 12).  Silaigwana and Wassenaar (2016) further assert 
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that efficiency of an REC depends upon many factors including the complexity of the proposed 
research, the quality of the submitted application, and the size and capabilities of the REC staff. 
Although many studies report the overall time to IRB or REC approval, there is no outlining of the 
time each party (e.g., researcher, reviewer) contributes to the overall review time. There are no 
data on the quality of the applications, the time it takes research ethics committee members to 
review, or the time it takes the researchers to respond to queries. 
 
According to Sonne et al., (2018) REC staff do not have sufficient time to devote to the correction 
of severely deficient applications.  However, their mandate remains as that of ensuring that human 
participants’ research is conducted in ways that minimize risk of harm and balance risks with 
minimal benefits.  
 
2.3 RECs in South Africa 
South African guidelines on ethics in health research were first issued by the Medical Research 
Council in 1979 (revised 1987, 1993, 2002 - 2005). This sequence is not different from other 
unions outside of South Africa. Previous research shows that seeking ethics approval for health 
research was initially a natural decision of acting in good faith for South African researchers, 
reinforced by internal regulations of the various host institutions (Cleaton-Jones & Wassenaar, 
2010). In 1996 this improved with the introduction of the Constitution of South Africa, which 
states: “Everyone has the right to bodily and psychological integrity, which includes the right: a) 
to make decisions concerning reproduction; b) to security in and control over their body; and c) 
not to be subjected to medical or scientific experiments without their informed consent” 
(Constitution of the Republic of South Africa, 108 of 1996, 12(2)). 
 
The National Health Act became law in 2005; this legally requires that ethics approval of research 
should be sought by researchers from a registered REC prior to research commencement. The 
South African Health Act mandates that, every health-related research together with social and 
behavioural research that is done in South Africa has to be reviewed by an NHREC registered 
research ethics committee, and must adhere to the stipulations of the South African Research 
Ethics guidelines (2015) and with the South African guidelines on good clinical practice if it’s a 




In South Africa, all proposed research studies with human participants, irrespective of its nature 
or discipline, require ethics review. However, according to section (2) of 46.101 of the Common 
Rule in the United State of America; interviews, surveys, and behavioral studies, if not potentially 
harming, are exempt from ethics review in the USA. Studies using existing data already in the 
public domain are also exempted from ethics review. Section 2 of the Common Rule further 
exempts research on diagnostic and pathological specimens, but in South Africa each research use 
of specimens is scrutinized afresh to ensure that it is in accordance with the protocol and informed 
consent before they are approved by RECs. Another significant difference regards informed 
consent, as in South Africa the likelihood of getting a waiver is small (Cleaton-Jones &Wassenaar 
2010). Furthermore, consent documentation and age of consent for minors is not the same, as South 
African requirements are more rigid (Hebert & Saginur, 2009).   
 
2.4 Research ethics guidelines 
Research ethics is concerned with how human beings are treated when participating in research. 
Most of the time, scientific activities or anything to do with research is achieved with an 
involvement of human beings as research participants. Hence, it is vital that researchers be 
acquainted with ethical issues and the possible effects of their scientific work, and act accordingly. 
This includes fashioning ethical judgements that are contextually informed by literature, relevant 
guidelines and morality. 
 
The Nuremberg Code emerged as a part of international disapproval of violence by Nazi 
physicians. It concentrated on the issues of consent and a favourable risk-benefit ratio in clinical 
research (Emanuel et al., 2004). The research scandals of Tuskegee and Willowbrook, led to the 
development of the Belmont Report.  Belmont Report similarly emphasized the importance of 
informed consent (Beauchamp, 2008). Then, the Declaration of Helsinki, emphasized the need for 
favourable risk-benefit ratio in research as well as independent ethics review, and delineated the 
ethical guidelines for doing biomedical research (Emanuel et al., 2004).  
 
The Second World War and the Nuremberg trials of doctor-researchers revealed biomedical 
research that was unethical. After World War II, scientists started to be more responsive to ethics 
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in biomedical research. The validity and quality of unethical research was critiqued, and 
participants’ human rights were recognised and respected, leading to the formation of ethical 
codes. The Nuremberg Code (1947) was followed by the Declaration of Helsinki in 1964, which 
was modified many times afterwards (World Medical Association, 1989). The Council for 
International Organisations of Medical Sciences (CIOMS) and the World Health Organisation 
(WHO) also proposed guidelines in 1983 and adapted them in 1992, 2002 and 2016. These 
international developments motivated many initiatives at the national level and in countless fields 
of biomedical research. 
 
The Declaration of Helsinki, issued by the World Medical Association in 1964, has been looked 
up to as an ultimate manuscript in the field of ethics, especially in biomedical research and has 
inspired the construction of worldwide and local legislation and codes of conduct. It has been, 
revised a number of times, of late in 2013. It sets out ethical guidelines for practitioners engaged 
in both clinical and non-clinical biomedical research. According to the Declaration of Helsinki, 
“the research protocol must be submitted for consideration, comment, guidance and approval to a 
research ethics committee before the study begins. This committee must be transparent in its 
functioning, must be independent of the researcher, the sponsor and any other undue influence and 
must be duly qualified” (Declaration of Helsinki, 2013, paragraph 23) 
 
Research ethics committees are expected to reflect the regulations of the country where research 
is conducted. Relevant international norms and standards should also be considered but not 
dropping or abolishing any of the protections for research participants set forth in the Declaration. 
The committee should have a right to monitor studies that are in progress. However, ethics review 
in health-related research is occasionally antagonistic, with contemporary mediations arguing that 
most ethics review of health research is complacent. According to Angell and Dixon-Woods (2009, 
p. 797), RECs are struggling to accept the “quality of science from peer review conducted before 
applications are seen by RECs” 
 
CIOMS foresaw that it is imperative that guidance is provided to researchers, sponsors, members 
of research ethics committees, and other stakeholders in dealing with these challenges; thus a 
revision process was started. 
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2.4.1 Revision of CIOMS guidelines 
As an overall reaction, the scope of the CIOMS guidelines has been extended from purely 
biomedical research to include health-related research; this is because the term biomedical research 
would not cover research with health-related data. In addition, the 2002 International Ethical 
Guidelines for Biomedical Research Involving Human Subjects were combined with the CIOMS 
2009 International Ethical Guidelines for Epidemiological Studies, which included topics such as 
bio-banking and research with health-related data. 
 
Changes have been made as a response to the specific challenges that have risen during the last 
decade. First, the “2016 CIOMS guidelines put an emphasis on the scientific and social value of 
research: the prospect of generating the knowledge and the means necessary to protect and promote 
health (guideline 1)” (van Delden & van der Graaf, 2017, p. E1). “Researchers and sponsors should 
see to it that research addresses significant and mysterious queries to improve health and increase 
the reliability of scientific information and reduce research waste” (van Delden & van der Graaf, 
2017, p. E1). 
 
“CIOMS (2016) now sets forth the responsibility to make obtainable the interventions that have 
been proved to be operative in research as part of a broader responsibility to care for participants’ 
health needs (guideline 6)” (van Delden & van der Graaf, 2017, p. E2). This broader responsibility 
requires, for example, that before the commencement of the study, researchers and sponsors make 
provision for transitioning participants, who continue to need treatment after their participation in 
research to appropriate health services. Moreover, the revised guidelines “require researchers and 
research ethics committees to evaluate the specific context-dependent characteristics that may 
place study participants at increased risk of being harmed or wronged” (van Delden & van der 
Graaf, 2017, p. E2). “Researchers and research ethics committees can formulate special protections 
for groups considered to be vulnerable, including allowing for no more than minimal risks for 
research procedures that offer no potential individual benefits for participants” (van Delden & van 





According to guideline 23 (CIOMS, 2016), RECs may function at a local and/or a national level. 
Their establishment must be in accordance with regulations set by a national or other recognized 
authority. Institutions must encourage undeviating standards for committees within a country. 
There should be sufficient resources allocated for the ethical review process.  “Committees should 
either carry out a proper scientific review, confirm that a knowledgeable expert body has accepted 
the research as scientifically rigorous, or consult with competent experts to ensure that the research 
design and methods are appropriate” (CIOMS, 2016; guideline. 23, p. 87). If RECs do not have 
expertise to judge science or feasibility, they must co-opt persons with relevant expertise. 
 
2.5 What is ethical? 
RECs are faced with situations where there is no answer that is particularly ‘right’ to most ethical 
issues, especially when it comes to medical research (Dixon-Woods, Angell, Ashcroft & Bryman 
2007). Even if there was common ground on other issues, there would be opportunity for analysis 
and diverse verdicts (Dixon-Woods et al., 2007). Studies show that RECs’ ethical opinion varies 
when deciding about the same protocol. As much as reviewers may try to consider all ethical issues 
relating to proposed research, ethical guidelines also contradict one another.  
 
However, assuming that ways to approach ethical issues are many (utilitarian versus human rights, 
for example), different outcomes are likely to be reached (Angell, Sutton, Windridge, & Dixon-
Woods, 2006; Angell et al. 2007; Edwards, Stone, & Swift, 2007). Without an ultimate ethical 
authority in determining what is deemed as ethical, it can be hard to lay down what should be the 
‘correct’ reaction to any perused research proposal. “In the face of the unclear nature of ethical 
decision making, the purpose of the REC response is to guide the connotation of ‘what is ethical’ 
for each application” (Dixon-Woods et al., 2007, p. 795). Significantly, thus, RECs’ responses 
function to outline what is reasoned by a REC to be ethical practice, and deliberate reliability on 
that definition. 
 
RECs’ responses may guide the meaning of ‘what is ethical’ in two distinctive ways (Dixon-
Woods et al. (2007). First, they find those aspects of the protocol relating to ethical themes or 
subject enquiry and concern.  Occasionally, it is obvious what one can judge as an ethical issue; 
i.e., the informed consent process. Tsoka-Gwegweni and Wassenaar (2014) found that informed 
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consent was the most common ethical issue considered by the biomedical REC that they studied. 
This shows that RECs pay attention to consent because this is an obvious way of protecting 
potential participants and an obvious platform for understanding most of ethical issues of that 
particular study. In other cases, it is less obvious what counts as an ethical issue, or why it might 
engage the attention of the REC and this is where available guidelines are helpful.  
 
Secondly, RECs actively or passively put forward what ethical compliance entails. If the REC does 
not respond to researchers’ projected provisions, it is passively accepting the researchers’ 
proposals. If the REC comments, it actively suggests amendments from the researchers. In so 
doing, responses may impose a number of vastly changing or unpredictable requirements on 
researchers, for example, in prescribing the period of time that data should be stored for. 
 
The quality of ethics review within RECs is questionable. The fact that an Ethics review committee 
approves debatable studies might not necessarily be an indication of competence nor 
incompetence; it may be a result of a counterbalanced contemplation of social value and scientific 
validity, and examination of risk-benefit ratio. South Africa is transforming into a free country, in 
which autonomy, fairness, and the exploration of human rights are appreciated, encouraged, and 
safeguarded by the South African Constitution Act, 1996 (Act No. 108 of 1996). Particularly, 
section 12(2) of the Bill of Rights provides that “everyone has the bodily and psychological 
integrity, which includes the right (b) to security in and control over their body; and (c) not to be 
subjected to medical or scientific experiments without their informed consent”. 
 
2.6 The meaning of risk  
The multiplicity of approaches that are used in biomedical science creates a number of risks that 
biomedical scientists and RECs have to manage. According to Brink, Van der Walt and Van 
Rensburg (2006), risk is often understood with reference to the possible physical or psychological 
harm, distress or strain to human participants that may be generated by participating research. This 
is commonly accepted in the perspective of health-related research but, additionally, social science 
brings about a different range of risks that need to be taken into consideration by RECs (Wassenaar 
& Mamotte, 2012). These comprises of risks such as; personal social standing, confidentiality, 
personal beliefs and views, occupations, their links to family and the community, emotional 
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distress, and stigma attached to revealing information that relates to socially stigmatised or non-
conforming behaviour (Wassenaar & Mamotte, 2012).  
 
Research that has no physical risk could bring about concerns and risk to research participants 
either as individuals, groups or as entire communities, because, as much as that particular research 
may not be physically threatening, it may carry psychological risk such as stigma.  It may be 
complex get these risks quantified before the commencement of a research study. Nonetheless, 
researchers are expected to try their best to determine all possible risks and have relevant solutions 
for potential risks prior to the start of a project. Furthermore, after identifying risks, they should 
then be discussed with research participants so that appropriate informed consent can be obtained 
(Pope, Ziebland & Mays, 2000). Ordinarily, researchers have a duty to maintain that research 
participants are knowledgeable of and agree, by consenting, to the provisions in place for the 
anticipated risks. 
 
2.7 Ethics review as a tool of power 
It has been argued that RECs somehow influence researchers and participants in ways that may be 
opposing to the conduct of ‘ethical research’. Halse and Honey (2007) argue that research ethics 
committees are changing their goal of promoting good research through ethics review. They argue 
that ethics is becoming “a system of governmentality generating its own discursive systems, 
meanings and representations of the world” (Halse & Honey, 2007, p. 339). This discourse is the 
product of principles and actions employed by institutions for researchers to practice within the 
requirements of ethics. It functions “as both an ideology and an instrument of governmentality, 
that encompasses an ever-expanding suite of technologies, structures and practices, including a 
new class of professional committed to its political ethos” (Halse & Honey, 2007, p. 341). These 
dispositions of governmentality, fundamental to the establishment of strategic discourse about 
ethical research, are characterized by REC practices and requirements. 
 
Lincoln and Tierney (2004) maintain that RECs, most of the time, block studies which employ 
unconventional methods. Research ethics’ governing practices might certainly have effects on the 
likelihood of alternative approaches and ultimately, the construction of new knowledge. This 
discourse may also unknowingly nurture the very unethical research it seeks to do away with. As 
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Halse and Honey (2007, p. 344) asserted, “there is always a danger that what is taken to be ethical 
research within institutions will be reduced to no more than a performance by researchers of a suite 




The chapter reviewed studies that looked at ethics review approval times, to confirm whether there 
was any trend in ethics review approval times. Several studies confirmed that there were excessive 
delays in ethics approval turnaround times. The chapter outlined the ethics guidelines in relation 
to ethics review processes and discussed what is ethical and the meaning of risk.  The current study 
sought to understand the turnaround of the UKZN/BREC expedited review process. The following 




















CHAPTER 3: METHODOLOGY 
 
3.1 Introduction 
This chapter focuses on the approach and the research design adopted for this study. This is 
followed by a description of sampling and data recording. The chapter concludes by reflecting on 
the ethical issues relating to the study and a description of the data analysis conducted. 
 
This was a quantitative exploratory study. Firestone (1987) asserts that, quantitative methods adopt 
a positivist perspective that says that one can interpret actions quantitatively. The reason adoption 
of this method was to clarify information through unbiased dimensions and quantitative analysis 
(Firestone, 1987). The design, being exploratory, was chosen to allow for an inductive tactic to 
research (Terre Blanche, Durrheim & Painter, 2006). Quantitative scholars such as Ayer (1959), 
Maxwell and Delaney (2004), Popper (1959), and Schrag (1992) have argued that social studies 
have the potential to be studied the same way as scientific studies and hence should be studied the 
same way (Johnson & Onwuegbuzie, 2004).  
 
Quantitative methodology and the use of exploratory design are used in order to reduce error and 
bias that may compromise the study’s validity (Firestone, 1987). A study such as this, that seeks 
to explore the timelines of the expedited ethics review process, is best approached using a 
quantitative exploratory research design. Two instruments were used in this study, one was the 
data pro forma (Appendix A) to document and measure the timelines of the expedited ethical 
review process and the other was a taxonomy (Appendix B) to categorise the acceptability of the 
period of time taken for each phase of the review process. The development of taxonomy was 
informed by previous literature on ethics review turnaround time.  For example in the study 
conducted by (Adams, Kaewkungwal, Limphattharacharoen, Prakobtham, Pengsaa & Khusmith, 
2014) the customary duration from the submission of protocol submission to the time of approval 
was set at 60 days. This was based on protocol submissions for the monthly REC meetings. The 
average number of days from submission to first notification was about 30 days, plus on average 
another 30 days until final approval (making the total average from submission to approval about 




In contrast, the qualitative research paradigm does not accept positivism; it argues for interpretive 
and constructionist approaches to research (Johnson & Onwuegbuzie, 2004). Researchers who 
adopt this paradigm have confidence that there exist several constructed truths and that the knower 
and what can be known are inseparable (Guba, 1990; Terre Blanche, Durrheim, & Painter, 2006). 
Despite the significance of being able to discover multiple accounts of a given phenomenon that 
qualitative methods make possible, the purpose of this study, which is to review and quantify the 
time it takes for the expedited review process, it was most appropriate to use quantitative 
methodology. 
 
According to Johnson and Onwuegbuzie (2004), quantitative research has strengths and 
weaknesses. A thorough perusal of the following strengths and weaknesses led to the quantitative 
methodology used in this study. The first of these strengths, as discussed by Johnson and 
Onwuegbuzie (2004), is that data collection can be speedy. Because of time constrains pertaining 
to conducting this research, this research method was assessed and deemed  to be appropriate in 
meeting the objectives set for the study. Secondly, a quantitative research method is expedient in 
its ability to offer accurate numerical data. Another strength of the quantitative research method is 
that it is useful when working with large numbers, given the large number of cases that were 
included in this study. 
 
However, there are some weaknesses associated with quantitative research that Johnson and 
Onwuegbuzie (2004) identified, and these were also noted when choosing and using this method. 
The most relevant of these to this study was that it is a narrow research method that can miss other 
important information related to the phenomenon under investigation. Exploring the expedited 
review process has the danger of missing other important internal and underlying variables, for 
example, administration, filing, etc., which may be contributing to ethical review delays. However, 
important as it is to explore all explanations of human phenomena, it is not always practical. 
Methodological approaches such as the one used in this study seek only to explore, describe and 







This section will describe how sampling was done and offer a justification for the choice, given 
that numerous sampling methods are available for studies like this. De Jongh (1990, p. 46) refers 
to a sample as “a model of the population or a subset of the population that is to be used to gain 
information about the entire population”. A population can be defined as the entire list of cases 
that the study is interested in (Monette, Sullivan & De Jong, 1989). According to Monette et al. 
(1989, p. 132), a representative sample is one that “accurately reflects the distribution of relevant 
variables in the target population”. 
 
The first step in sampling was to decide what population one plans to study and according to Kish 
(1965), selection of the population should be based on four factors: content, units, extent, and time. 
‘Content’ refers to a distinguishing feature that all members of the population of interest have in 
common. The unit refers to what the study is interested in studying, i.e., individuals, groups or 
organisations. This study was interested in examining the timelines in expedited ethics review 
process at the Biomedical Research Ethics Committee, University of KwaZulu-Natal. Extent refers 
to the geographical coverage of the study, which was the University of KwaZulu-Natal, 
Biomedical Research Ethics Committee. Time refers to a period that the units possess, and the 
characteristics that qualify them for participation in the study.  
 
The sampling method used in the study was a convenience sampling method and will be described 
below. Sampling has a substantial role in determining the statistical validity of a study. The 
statistical validity of the study is furthermore determined by sample size (De Jongh, 1990). In this 
study, a large enough sample was hopefully used in order to reduce the possibility of statistically 
invalid results. A convenience sampling method was judged to be the most appropriate for this 
study after careful scrutiny of the following sampling methods. Probability sampling is one 
sampling method that allows for randomness, which maximises the chances that most members of 
a population of interest are included in sample for the study (Bryman, 2001). This type of sampling 
is deliberately structured to reduce researcher bias in the way he/she selects the sample. 
 
Non-probability sampling is less structured than probability sampling and incorporates human 
judgement in the sample selection process (De Jongh, 1990). There are six types of non-probability 
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sampling designs (Henry, 1990). The first is convenience/availability sampling. With this 
sampling method, cases are selected based on their availability. The second is most 
similar/dissimilar cases. According to this method, cases are selected based on their apparent 
similarity or dissimilarity with the conditions of interest.  
 
The third design is typical cases. Cases using this design are selected based on their known 
usefulness and lack of extremity. The fourth design is the critical cases design; for this design, 
only the essential and key cases for what is being investigated are selected for the sample. The 
fifth design is the snowball design. With this design, sample members that have already been 
judged to be appropriate for the study recommend to the researcher other similar cases known to 
them. The sixth design is the quota design; with this method, the researcher selects a representative 
sample for the study based on readily identifiable characteristics. Non-probability sampling often 
makes the results of the study hard to generalize because they usually reflect the views of a 
restricted sample.  
 
To minimize error discrepancy, it would have been ideal to use probability sampling in the current 
study. However, due to time constraints, non-probability convenience sampling was employed. 
Convenience sampling was found to be useful because the investigator in the current study had 
easier access to UKZN/BREC database. 
 
3.3 Data collection 
The design of the study was exploratory. Data was readily available from the UKZN/BREC 
database subject to the permission of the UKZN Dean of Research, the chair of UKZN/BREC, and 
the UKZN Registrar (Appendix C). Gatekeeper permission was sought and obtained through 
letters to the above respective officers. Ethical clearance Ref number BE 347/16.   
 
The researcher sampled and reviewed 200 records of research proposals submitted to BREC for 
expedited review in two consecutive years, 2013 and 2014. The researcher drew 100 cases from 
2013 and 100 cases from 2014. The researcher extracted every third referenced BREC expedited 
(coded as ‘BE’) application sent in for BREC review in the years 2013 and 2014, until the sample 
size of 200 cases was reached. Expedited review is a process applied to research that involves no 
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more than minimal risk. It requires review by one or two reviewers and does not serve at full REC 
meetings, and should thus reach a decision before having to wait for a monthly meeting. Expedited 
review is intended to be faster than full review and is justified by the lower level of risk (BREC, 
2010). 
 
The following information was extracted from each case: a) the application reference; b) the date 
on which BREC received the proposal; c) the date on which the application was sent to reviewers; 
d) the date on which it was received back from the reviewers; e) the date on which applicants 
responded to queries; and f) the date that full ethics approval was granted. A pro-forma for data 
collection (Appendix A) was used to record the dates respectively. Data was readily available from 
the BREC records which limits bias; in this manner therefore, validity and rigour are ensured. 
The results will be related to current and emerging local and international literature on the 
efficiency of the ethics review process, ultimately with a view to identifying blocks in the system 
so that remedies can be designed. 
 
3.4 Ethical considerations 
It is significant that each time research is conducted, applicable ethical guidelines and 
considerations must be adhered to. For the purposes of this study a brief review and consideration 
of these different guidelines was done to ensure that the study is conducted ethically. Below are 
the eight ethical requirements as asserted by Emanuel et al. (2004) which were considered for this 
study.  
1. Collaborative partnership - this means that there should be ongoing partnerships with 
researchers, makers of health policies, and the community (Emanuel et al., 2004). 
Everyone should be involved in sharing responsibilities for determining the importance of 
that particular research, assessing the value of research, etc. In this study, there has been 
ongoing supervision, the BREC chair and Dean of research deemed the study to be 
necessary and of potential value to the REC.  
2. Social value - research must result in some value for people, for example, institutional 
improvement, better health or wellbeing, etc. According to this requirement, studies that 
are not implementable are probably neither valuable nor ethical (Emanuel et al., 2004). 
The current study was intended to identify specific phases in the review process 
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associated with delays in the time taken to obtain ethical clearance.  This could possibly 
help the ethical review process be improved.  
3. Scientific validity - this requirement calls for studies to be methodologically sound in order 
to be regarded as ethical (Emanuel et al., 2004). The objectives of the study must be clear, 
the design principles and methods reliable and able to test the objectives of the study. The 
current study adhered to widely accepted research methods and processes that addressed 
the objectives of the study and were judged to be so by independent reviewers of the School 
of Applied Human Sciences at the University of KwaZulu-Natal. The methodological 
process was regularly revisited and reviewed throughout the duration of the study to ensure 
that it remained sound and consistent with the objectives of the study. This study was also 
supervised by an experienced researcher. This supervision ensured that the scientific rigor 
of the study was monitored and maintained throughout the duration of the study and that 
the researcher remained objective at all times. 
4. Fair subject selection - selection of participants or data must address the scientific goals of 
the study. Only sound scientific reasoning can justify the exclusion of participants from the 
study. This study did not use any human participants and non-probability convenience 
sampling was used; as discussed earlier, this was because it is the scientifically accepted 
method of sampling when one takes advantage of the accessibility and availability of the 
data of interest as was the case in this study.  
5. Favourable risk-benefit ratio - this requirement highlights the need for clinical studies to 
minimize risk for participants and increase the benefits; benefits should always outweigh 
the risks (Emanuel et al., 2004). Extraneous benefits like money are not included in this 
definition of benefits, as increasing how much one pays participants will not necessarily 
reduce the risk that the study poses (Emanuel et al., 2004). There were no risks identified 
in this study, since there were no participants involved. Confidentiality of the identifiers in 
the BREC records accessed was assured and maintained and a confidentiality form was 
signed by the researcher. Only aggregated data are reported. 
6. Independent ethics review - this requirement refers to the oversight role of an independent 
research ethics committee that ensures that all studies adhere to acceptable ethical 
standards. Independent reviewer(s) can help ensure that scientific rigor and principles are 
not clouded by researcher interests (Emanuel et al., 2004). The Biomedical Research Ethics 
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Committee at the University of KwaZulu-Natal, whose responsibility it is to ensure that all 
research done by registered students is ethical, approved this study BE 347/16 (Appendix 
D). 
7. Informed consent - providing information in culturally and linguistically appropriate 
formats is very important for a research study to be judged ethical (Emanuel et al., 2004). 
Although in this particular study, informed consent was not applicable (since there were 
no human participants), thorough information about the study was given and permission 
was sought and obtained from relevant gatekeepers.  
8. Respect for recruited participants and study communities (Emanuel et al., 2004) - although 
there were no recruited participants in the study, procedures and measures to protect the 
confidentiality of the collected data were taken. The researcher did not record or use any 
identifying information from the protocols accessed and only uniquely coded protocol 
numbers were created and used.  
 
3.5 Data analysis 
Data analysis was done using SPSS. The researcher had to first quantify the collected data. Data 
was quantified into the number of days taken for each of the phases in the ethics review process. 
There were no formulas required. The researcher calculated the days it took for each phase of the 
ethics review to be completed. The researcher calculated this independently and then entered 
values into SPSS to obtain descriptive statistics: Mean, Median and Mode.  Researcher left blank 
the spaces for the ethical review phases that did not have any dates and for the studies that were 
not approved to date. Of the 200 cases that were drawn, 100 expedited (BE) cases were from 2013 
and other 100 expedited (BE) cases were from year 2014. However only 87 cases from the year 
2013 ended up being used for 2013 due to missing values and extreme outliers; extreme outliers 
were data that was unable to be traced, cohort and longitudinal studies that were still not approved 
for more than five years which was prone to distort the data. Such cases were probably not revised 
and resubmitted to the REC after the initial review and should have been closed by after six 
months. A Taxonomy (Table. 3.5.1.) was developed in discussion with an experienced REC 
member, and was used to categorise the acceptability of the periods of time taken for each phase 




Table. 3.5 Taxonomy 
Time taken to complete each phase of the 
review process 
Acceptability 
3-4 weeks Highly Acceptable 
4-6 weeks Acceptable 
6-8 weeks Less than acceptable 
8-10+ weeks Unacceptable 
 
Data was then analyzed with descriptive statistics. Mode was examined, this was because 
considering only the mean is problematic because it is easily distorted by extreme outliers. There 
were no anticipated problems during the implementation of the study. However, during data 
collection the researcher encountered difficulty in obtaining data randomly as some files were not 
clearly recorded as expedited applications, files with inconsistent information and refiling of 
applications.  Results are intended to be published as a thesis and submitted to a peer-reviewed 
journal and a copy made available to the UKZN Research Office and BREC. 
The findings are related to current and emerging local and international literature on the efficiency 
of the ethics review process, ultimately with a view to identifying blocks in the system so that 
remedies can be designed. Data was readily available which limits bias, in this manner therefore, 
validity and rigour was hopefully ensured. The information explored in this study was gathered by 
a person permitted (Appendix C and D) to access the research data.  Almost all data that the 
personnel looked for was quantitative.  Therefore, the person who extracted data did not need to 
exercise any subjective judgment. The duration of the ethics review process, from submission to 
final approval of each protocol regarded as ‘highly acceptable’, was set at ≥30 days, 3-4 weeks in 
the devised taxonomy. 
 
3.6 Summary 
This chapter has provided a description and motivation for the exploratory quantitative design 
used in this study. This was accompanied by a description of data collected and why convenience 
sampling was judged to be appropriate for this study. All ethical considerations as discussed by 
Emanuel et al. (2004) were addressed and monitored throughout the duration of the study. The 
chapter that follows will present the results of this study. 
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CHAPTER 4: RESULTS 
 
4.1 Introduction 
This chapter describes the study findings based on the research questions and the taxonomy 
(Appendix B) that was developed for this study. The researcher considered 187 usable protocols 
of the 200 expedited protocols that were initially drawn from the years 2013 and 2014. Of the 
187 protocols, 163 protocols had been given full approval and, at the time of this research, 24 
protocols were still either not yet approved, or not recorded as approved. The results are accepted 
as accurate as they were quantified and analysed in exact number of days per stage of review. 
 
Mean, median and mode are all valid measures of central tendency, but when subjected to 
different circumstances, some measures of central tendency are more appropriate than others. 
The mean has one main disadvantage: it is particularly susceptible to the influence of outliers. 
On the other hand, one of the problems with the mode is that it is not unique, so it leaves 
problems when there are two or more values that share the highest frequency (Groth & Bergner, 
2006). The median also has a disadvantage in that it may be difficult to calculate in a large set of 
data, like in this study; however, it is a good measure of central tendency in that a very big value 
or a very small value do not affect it (Thompson, Diamond, McWilliam, Snyder, & Snyder, 
2005). Mean, median and mode are all considered in this research because they all contribute 
certain figures that are relevant to the data and present different ways of examining and 
describing the data (Groth & Bergner, 2006). The results are presented in the section that follows 













Table 4.2: Phase 1: The duration from the date on which BREC received the proposal to 
the date on which the application was sent to reviewers 
 Valid cases  178 
 Missing cases  9 
 Duration in days 
Mean   11.93 
Median   8 
Mode  1(25) 
 
Table 4.2 presents the data relating to Phase 1, which is the duration from the date on which the 
ethics office received proposals to when they were sent to reviewers. The obtained mean was 
11.93 days. The median was eight days and the mode was one day. The mode in this phase tells 
us that mostly it took one day for the ethics office to send proposals to reviewers. According to 
our guiding taxonomy, the modal time it took for this phase is ‘highly acceptable’ as it is shorter 
than the 3-4 weeks specified in the taxonomy. 
 
Table 4.3: Phase 2: The duration from the date on which the application was sent to 
reviewers, to the date on which reviewers returned their reviews 
 Valid cases 171 
 Missing cases 16 
 Duration in days 
Mean  24.22 
Median  18 
Mode  1(12) 
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Table 4.3 shows Phase 2 which is the duration it took the reviewers to review protocols.  This 
records the number of days between the date on which it was sent to reviewers to the date on 
which the reviewers returned their reviews. It shows that it mostly took only one day for 
reviewers to review and send feedback as the mode was equal to 1. However, the mean and 
median, although affected by the extreme outliers, show that it took a mean of 24.22 days and a 
median of 18 for the reviewers to return their reviews. According to our guiding taxonomy, the 
time it took this phase is ‘highly acceptable’ as it ranges below 3-4 weeks of the taxonomy. 
 
Table 4.4: Phase 3: The duration from date on which the reviews were returned by 
reviewers, to the date on which applicants responded to queries 
 Valid cases 163 
 Missing case 24 
 Duration in days 
Mean  65.85 
Median  42 
Mode  14(8) 
 
Table 4.4 presents the data relating to Phase 3, which is the duration from the date provisional 
approval was given to the date on which applicants responded to queries. This phase was for 
finding out how long it took the applicants to respond to queries. The mode was 14 which means 
that most of the time it took applicants 14 days to respond to the reviewers’ feedback. The mean 
was 65.85 days and median was 42 days. For this phase, although the mode of 14 days means 
this phase falls under the ‘highly acceptable’ category, the mean shows that it took almost three 
months for applicants to respond to queries. According to our guiding taxonomy, the time it took 





Table 4.5: Phase 4: The duration from the date on which applicants responded to queries to 
the date on which ethics approval was given 
 Valid cases 153 
 Missing cases 34 
 Duration in days 
Mean  41.20 
Median  17 
Mode  1(16) 
 
Table 4.5 presents Phase 4, which is the duration from the date on which applicants responded to 
queries to the date on which ethics approval was given.  This is the final phase of the expedited 
BREC review process and its turnaround time is highly dependent on how fast the committee 
reviews necessary amendments. It shows that after applicants have fully responded to queries, 
full approval is usually granted, with the mode as one day, although the mean and median were 
41 and 17 days, respectively. According to our guiding taxonomy, the time it took this phase is 
‘acceptable’ as it ranges above the 3-4 weeks specified in the taxonomy. 
 
Table 4.6: The duration period it took the entire ethics process to be completed 
 Valid cases 163 
 Missing cases 24 
 Duration in days 
Mean   155.72 
Median  136 




Table 4.6 shows the duration from the date on which protocols were received from the applicants 
to the date on which they were finally approved by the BREC. It shows a mode of 140 days (5 
months or 20 weeks), and a mean and median of 155.72 and 136 days, respectively. According 
the results, shown in Table 4.2.5, the total duration of the UKZN/BREC expedited review 
process falls under the ‘unacceptable’ (more than 8-10 weeks) category of the taxonomy.  
 
Table 4.7: The turnaround times (in days) of the expedited review process at 
UKZN/BREC 
  Phase 1 Phase 2 Phase 3 Phase 4 Total duration 




Valid cases 178 171 163 153 163 
Missing cases 9 16 24 34 24 
Duration in days 
Mean  12 24 66 41 156 
Median  8 18 42 17 136 












Fig 4.2.1: The turnaround time (in days) of the expedited review process at UKZN/BREC 
 
 
Fig.4.2.1 shows that Phase 3 of the UKZN/BREC expedited review process took the longest, 
compared to other phases. In terms of duration, these phases can be ranked in descending order 
as follows: Phase 3 > Phase 4 > Phase 2 > Phase 1. According to this study, Phase 3 shows the 
duration between the provisional approval and the responses of applicants to queries. Thus, this 
phase records how much time it took applicants to respond to queries. The results showed that it 
took a mean of 65.85 days, a median 42 days and a mode of 14 days for applicants to respond to 
reviewers’ feedback. 
 
Table 4.8:  Pre-review versus Post-review 
 Pre-review (Phase 2) Post-review (phase 4) 
mean 24 41 
median 18 17 
mode 1(12) 1(16) 
 
Table 4.8, show the difference between the time it took initial phase of the review process and 
the time it took the final phase of the review process. The results show that it took a mean of 24 
for the first review and the mean of 41 for the final review. The median was 18 and 17 


























According to this study, Phase 4 was the second longest phase of the UKZN/BREC expedited 
review process. Phase 4 shows the duration from the date on which applicants responded to 
queries to the date on which ethics approval was given. In this study, this phase was for finding 
out how much time it took the committee to issue to give full approval after applicants had 
responded to queries. The results showed that it took a mean of 41.2 days, a median of 17 days 
and a mode of one day for reviewers to give full approval after queries had been responded to by 
applicants.  
 
According to this study, Phase 2, was the third longest phase of the UKZN/BREC expedited 
review process. Phase 2 reflects the duration from the date on which the application was sent to 
reviewers to the date on which reviewers returned their reviews. In this study, this phase was for 
finding out how long it took the reviewers to return reviews. The results showed that it took a 
mean of 24.22 days, a median of 18 days and a mode of one day for the reviewers to return their 
reviews. 
 
Phase 1, according to this study, was the shortest phase of all other phases in the UKZN/BREC 
expedited ethics review process. Phase 1 is the duration from the date on which BREC received 
the proposal to the date on which the application was sent to reviewers. In this study, this phase 
was for finding out how much time it took reviewers to receive applications after applications 
had been sent to the BREC office. This phase showed that it took a mean of 11.93 days, a median 
of eight days and a mode of one day for the BREC office to send applications to reviewers. 
 
4.3 Summary  
It can be said that most results for each phase of the ethical review process fell into the ‘highly 
acceptable’ category of the taxonomy; however, the total duration of the entire UKZN/BREC 
expedited review process showed that it took a mean of 155.72 days, a median of 136 days and a 
mode of 140 days, which means that, it often took about 140 days (20 weeks) for the entire 
UKZN/BREC expedited ethics review process. This seems slow for expedited review. The 
results also show that the longest portion of the review process was the time taken by applicants 




CHAPTER 5: DISCUSSION 
 
5.1 Introduction 
This chapter covers the main findings relating to the two research questions in line with the study 
objectives. The findings show that for the entire expedited review process, the modal time it 
takes is 140 days with a mean of 155.72 days. This finding concurs with several studies that 
looked at RECs’ duration to approve studies, especially in the US (Abbott & Grady, 2011; 
Mamotte & Wassenaar, 2009). As also confirmed by Ashcraft and Krause (2007), 50% of the 
‘slow’ documented times went beyond a five-week turnaround time, and 20% went beyond three 
months. This was further confirmed by Clarke (2012, p. 24) as he concluded that “obtaining 
ethics approval for MMed studies was a lengthy process” and Cleaton-Jones (2010) who found 
that few studies received full approval at the first review, which prolongs the duration of the 
ethics approval process. 
 
5.2 What are the modal and average times taken for BREC review of expedited 
applications? 
The results show that the modal time taken by BREC review of expedited applications was 140 
days and the average time taken by BREC review of expedited applications was 155.72 days. 
This finding is not unusual, as there is considerable literature verifying the bureaucratic 
deferments relating to ethics review. For example, Cleaton-Jones (2010, p. 21) reported that in 
2003 and 2007, “out of 1 180 ethics applications at his institution, 27% were approved at the first 
sitting, 69% required revision, and 5% were rejected”. Cleaton-Jones (2012) looked at this again 
in 2010, and found that 37% of proposals were accepted at the initial sitting, 59% required 
revision, and 4% were rejected. Angell et al (2009) in the UK had similar rates. They reported 
that, over the period July 2005 - April 2006, 15% of proposals were approved at the initial 
review, 64% required revision, and 8% were rejected. No data was provided by these authors on 
actual days involved.  
 
5.2.1 Negative impact on academic progress and knowledge generation 
Results showed that the modal and average for the time taken by UKZN/BREC review of 
expedited applications were 140 and 155.72 days, respectively. This, at most was a duration of 
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five months. Five months is a significant amount of time for applicants to be anticipating their 
study’s ethics approval. This delay had previously been confirmed by other scholars. For 
example, according to Clarke (2012, p. 24), it took an average of 14.8 weeks (103 days) for 
BREC to approve “each of 53 proposals (range: 3-32 weeks). Of these, 21 (39%) received 
provisional approval in the first response”. Specifically for multi-center studies, Ahmed and 
Nicholson (1996) assert that, overall, one-third of local RECs were unable to approve a project 
within three months, and three of the 36 (8%) took longer than six months. Although these 
figures were reported twenty-one years ago, they suggest that obtaining ethics approval remains 
difficult and time consuming. 
 
According to Ashcraft and Krause (2007, p. 12), “time (i.e., waiting time for approval) appears 
to be the main reason for violating federal regulations about prior REC approval. In fact, time 
was even mentioned by three respondents”. The same applies to the current study. The slow 
turnaround time presented in this study has the potential to affect researchers’ choice of research. 
Researchers might resort to research that requires no external gatekeeper permission or even 
research that involves no human participants, in order to avoid ethics approval delays. This, 
therefore, can result in research value being diminished, and important and critical research not 
being done (Cleaton-Jones, 2010). According to Baarts (2009), research ethics is based on the 
researcher’s understanding of the subject of inquiry: “both scientific knowledge of the topic and 
insight into the role and status of the subject matter. However, the inevitable uncertainty 
involved always makes an ethical decision ‘greater’ than the researcher himself” (Baarts, 2009, 
p. 433). 
 
While researchers have a responsibility to familiarize themselves with the ethics review process 
at their institution, there is also a need for institutions to actively educate their academic staff and 
students on the ethics review process. Not only in terms of the requirements that need to be 
fulfilled, but in terms of the purpose, goals, process, and practices of the research ethics 
committee (Wassenaar and Slack, 2016). The ethics education of researchers should not only be 
at the level of relating documentations, but should show how distinctive ethical issues are 
resolved in areas where there is much uncertainty. For example, workshops could be scheduled 
in which specific research problems are examined or in which simulated good and poor protocols 
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are presented and discussed with the opportunity for mutual learning. According to Wassenaar 
and Slack (2016, p. 310), “applicants should use a systematic framework to think about ethical 
issues in their research and application.  The framework that is most applicable and all-inclusive 
is that, proposed by Emanuel, Wendler, Killen, and Grady, (2004)” 
 
5.3 Which phase of the review process took the longest? 
There is an often overlooked distinction, when discussing turnaround time, between pre-review 
delays and post-review delays. The pre-review is the review that results in provisional approval 
and the post-review is the review that follows after applicants have responded to provisional 
approval queries; post-review typically results in full approval. In this study, the results showed 
that Phase 3, the time taken by researchers to respond to provisionally approval queries, was the 
largest component of the pre-approval delay period and this ended up affecting the whole review 
process turnaround time. More research is needed to verify and explore this element of slow 
approval times. 
 
As argued above, Phase 3 is the duration from the date on which the review was returned to the 
applicants from the reviewers, to the date on which applicants responded to queries. As shown in 
Table 4.2.3, this was the phase that took the longest, with a mode of 14 days and a mean of 65.85 
days. This can be interpreted as applicants taking almost three months to respond to queries. It is 
highly noticeable that there is a lack of association between protocol submission and approval 
time, as much as results of this study show that applicants are the ones who delay. However, 
factors around the applicants’ delays in responding cannot be assumed to be solely associated 
with laziness. Further investigations on what makes applicants respond slowly to reviewers’ 
queries is recommended, because if it is a matter of straightforward amendments, the turnaround 
time for this phase should have been no more than four weeks. 
 
5.3.1 Pre-review versus post-review 
When one compares the turnaround time of the two review phases (the pre-review which in this 
study is Phase 2 and the post-review which is Phase 4), the results showed that Phase 2 took a 
mean of 24.22 days while Phase 4 took a mean of 41.20 days. This shows that the pre-review 
Phase 2 took a much shorter time than the post-review Phase 4. One would expect that the 
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turnaround time for the pre-review and the post-review would be similar or slightly different. It 
can be further expected that the pre-review would be longer than the post-review; however, in 
this study, the pre-review phase had a shorter turnaround time than the post-review. 
 
The question to ask is why the post-review phase took longer than the pre-review. Generally, 
post-review should have a shorter turnaround time than pre-review because, with the post-
review, reviewers are already familiar with the applications and may recall all issues that were 
posed as queries in the pre-review.  The lack of an electronic review management system or 
understaffing could typically account for post-review period delays. However, “RECs cannot be 
held accountable for delays caused by researchers themselves while responding to legitimate 
REC queries and requirements” (Wassenaar & Slack, 2016, p. 312).  A longer post-review 
turnaround time is also seemed more likely to occur when revised applications are assigned to 
different reviewers who were not assigned for the same application in the original review. This 
has a potential to prolong post-review turnaround time as the reviewers would be faced with a 
situation where they have to review a previously reviewed application for the first time, and this 
may introduce endless queries resulting in a slow turnaround time of the UKZN/BREC expedited 
review process. 
 
As much as RECs should see to it that research is scientifically and ethically sound, they should 
not be the reason that research ends up being done late or not done at all due to their bureaucratic 
review procedures. The main concern of a REC should be to ensure that ethical standards are 
maintained, both in theory and in practice, and operate within the ethical and legal frameworks 
of its host country. It is possible that applicants delay in responding to queries due to 
discouraging or perhaps unachievable demands that reviewers request (cf. Tsoka-Gwegweni & 
Wassenaar, 2015). This could provide one explanation for the long delays of about three months 
that applicants take to respond to queries.   
 
5.3.2 Lack of ethics review knowledge 
A lack of knowledge of the principles and practices that govern REC decision-making and 
perhaps uncertainty of REC members may result in poor review. Halse and Honey (2007) assert 
that long turnaround times may unintentionally nurture the type of ‘unethical’ researcher that the 
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ethics process is seeking to exclude.  According to Ashcraft and Krause (2007), The REC was in 
short of members that were knowledgeable in the researcher’s field of study so that timely and 
necessary responses could be given. In their study, 22% of participants confirmed the statement 
that “My REC always takes a long time, regardless of the specifics of the proposal” (Ashcraft & 
Krause, 2007, p. 322). Furthermore, according to Ogunrin et al. (2016), the decision made on the 
first review of the protocol is strongly associated with the time the protocol is going to take in the 
ethics process. A provisional approval means that applicants must go through their protocols and 
resubmit them, and have it reviewed again by the REC. According to this study, revision and 
resubmission of applications potentially resulted in a considerable period of three months passing 
before a constructive judgment was achieved. Therefore, it can be said that provisional rather 
than immediate approval was associated with delays in timeous ethics approval. 
 
Researchers’ resistance and frustrations concerning the ethics review process can be separated 
into principled and pragmatic objections (Wassenaar and Mamotte, 2012). Principled objections 
are from those who assert that ethics review restricts academic freedom (Oakes, 2002; 
Wassenaar and Mamotte, 2012) and those who feel that there is an intrinsic responsibility in 
researchers and therefore ethics review is unnecessary and offensive (Whittaker, 2005). 
According to Dada and Moorad (2001), delays resulting from proposals being returned for 
revision are said to be the result of incompetence or poor ethics knowledge on the part of the 
researchers. This is also argued by Sieber (1992) who said that if researchers were more 
knowledgeable in the ethical dimensions of research, their applications would be unlikely to 
require revision. However, RECs may also be accused of incompetence in their reviews (Oakes, 
2002; Whittaker, 2005). Various frustrations linked to ethics review, could be reduced if 
applicants were motivated to get their protocols ‘right’ on the earliest time of submission 
(Wassenaar & Slack, 2016). 
 
5.3.3 Clearly regulate turnaround times 
Slow turnaround time of REC review affects researchers’ satisfaction with the ethics review 
process and their ethics compliance (Ashcraft & Krause, 2007; Liddle & Brazelton, 1996, 
Mamotte and Wassenaar, 2009). RECs should give researchers clear advance indication of 
typical review turnaround timelines and adhere to these wherever possible. RECs should also 
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ensure that researchers are familiar with REC submission dates and turnaround time so that 
researchers can factor the ethics review process into their schedules. Inadequate review may 
make researchers feel powerless and inclined to sabotage the review process (Seahloli, 2015). 
The Principles of Research Ethics Framework states that “research should be designed, reviewed, 
and undertaken to ensure integrity and quality” (Faden et al., 2013, p. 12). Some variations are 
allowed in exceptional research contexts.  
 
5.4 Summary 
Slow turnaround time of the UKZN/BREC appeared to be mainly influenced by the time 
applicants took to respond to queries and secondly by the time reviewers took to review and 
respond to revisions. The results established that the time it took the applicants to respond to 
queries was the longest phase of the UKZN/BREC ethics review process. The entire 
UKZN/BREC ethics review process took a mean of 155.72 days, a median of 136 days, and a 
mode of 140 days. This is a notably long and unacceptable duration for expedited studies to be 
approved.   
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CHAPTER 6: CONCLUSION AND RECOMMENDATIONS 
 
6.1 Conclusion  
The timeframes of a sample of expedited reviews at the UKZN/BREC were identified and 
evaluated and the phases in the review process associated with major delays in obtaining ethics 
clearance were identified. The study showed that the UKZN/BREC expedited review process 
had a slow overall turnaround time. The phase that contributed most to the slow turnaround time 
was Phase 3. This is the time it took applicants to respond to queries.  In other words, the time 
applicants took to submit amendments to the UKZN/BREC. This phase is not under the control 
of BREC. The applicants’ delay in responding probably has many contributing factors. Some of 
these factors could be inefficiency of applicants, discouragement by reviewers’ queries, 
receiving gatekeeper permission very late and other factors that could be confirmed by further 
research. Therefore, further research is necessary to establish what made applicants respond later 
than expected, and to confirm or disconfirm the above assumptions. Recommendations can then 
be made based on this outcome. 
 
In conclusion, according to Allen (2009), RECs reflect a system of control which guides 
researchers and the process of research. UKZN/BREC should improve administration and 
governance that empowers good research by collaborating with researchers in the ethics review 
procedure. An electronic review management system is likely to reduce those sections of the 
review and approval process that are under the REC’s own control. Researchers should also be 
willing to accept temporal realities that may not accord with their research anticipations and 
ideals. For example, an electronic ethics review management system like RHInnO Ethics. 
RHInnO Ethics aims to speed up the review process by improving efficiency. The system 
provides RECs with a secure, web-based solution for tracking research applications throughout 
the entire life-cycle of the research project. This will improve control of research activities by 
RECs and could contribute to safer and more reliable management of submitted materials and 






6.2 Study recommendations and further research 
This study showed that obtaining expedited ethics approval at the UKZN/BREC took an average 
duration of 155.72 days, with a mode of 140 days. The ethics review phase that took the longest 
was the period from the return of reviews to the time applicants responded to queries, with a 
mean of 65.85 days and a mode of 14 days. Reviewers also took time to review protocols - the 
average duration they took to pre-review protocols was 24.22 days, while for post-review the 
duration was 41.20 days. However, the longest delays were from the applicants themselves 
failing to respond to queries within an acceptable period of time. An in-depth qualitative study to 
look at factors contributing to these different delays is recommended as there are many studies 
that confirm that there are delays in the ethics review process. For example, a study by Ashcraft 
and Krause (2007) showed that some researchers end up doing modifications without going back 
to REC for approval, with the reason given being: “Yes, because I knew it would take the IRB 
too long to act on the modifications” (p.12) Specific studies on what makes researchers respond 
so slowly to ethics review queries are highly recommended as it appeared in this study that the 
time it took the researchers to respond to queries was the longest phase of the ethics review 
process. Furthermore, studies on understanding the pre-review and post-review turnaround times 
are recommended, as in this study the post-review phase happened to be longer than the pre-
review.  
 
6.3 Recommendations for interventions 
6.3.1 Clarify the requirements for expedited review 
UKZN/BREC should make clear to researchers, through clear and appropriate channels of 
communication (e.g. standard operating procedures and guidelines), what research qualifies for 
expedited review. Researchers and UKZN/BREC should, whenever possible, be mindful of the 
timelines within which they need to work and plan accordingly. UKZN/BREC should assign 
members whose expertise most closely matches the methodology of the study to conduct 
expedited review. Electronic submission and review systems should be implemented for 
expedited reviews, so that reviewing can be done quickly through online communication.  
 
The rate of first-time approved protocols can be increased if researchers improved the ethical 
standard of the initially submitted protocols. Improving the standard of protocols can assist in 
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moderating administrative workload. With lower REC administration workload, protocols will 
have the potential to be given priority and hence shorter turnaround time may be achieved 
(Cleaton-Jones, 2015). Furthermore, to avoid misunderstanding and misinterpretation of 
protocols, once reviewers are assigned to specific protocols, they can conduct ‘video call 
reviews’ with researchers through skype or any other possible video call application. This would 
mean that every researcher applying for expedited review will be required to have a skype 
account or any other similar account so they can clarify with reviewers where there seem to be 
complications. This could reduce misunderstanding of the protocol between the researcher and 
the reviewer and hence speed up the turnaround time at the UKZN/BREC.  
 
6.3.2 Assist researchers with protocol development and submission. 
UKZN/BREC should give regular workshops for researchers to help them to understand research 
ethics and protocol development (Wassenaar & Slack, 2016). There should be trained research 
ethics academics in every research-oriented department who are prepared to consult with 
investigators preparing a protocol, and wherever possible, there should be a senior BREC 
member in each research-oriented department who can consult informally in the project and 
protocol development stages. There should be ongoing improved training for REC members. 
This is not solely recommended for UKZN/BREC; rather, it is legal requirement (DoH, 2015), 
because it is not necessarily a matter of how well resourced a certain REC is, but rather it is a 
matter of how efficient it is in its review turnaround time. In addition, it is also a South African 
NHREC guideline requirement that “all REC members receive initial and ongoing training in 
research ethics” (p. 59), no argument is necessary for this point as it is a clear requirement for 
RECs.  
 
6.3.3 Undergo periodic evaluation 
“The RECs process is too important not to undergo periodic evaluation” (Office of the Inspector 
General, 1998a, p. 20). It is furthermore a requirement from the (DoH, 2015), that all South 
African RECs should be regularly audited. Audits can help UKZN/BREC to determine whether 
applications are reviewed within an acceptable period of time. In addition, they can help identify 
what slows applicants’ responses to the initial reviews, and whether slow turnaround times are 
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preventing critical, socially valuable research from happening (Office of the Inspector General, 
1998). 
 
6.4 Limitations of this study 
The sampling approach adopted in this study may have had a bearing on the reliability and 
validity measures. Further studies using a diverse, randomly selected and stratified sample and 
using additional qualitative methods could perhaps have shed more insight. Furthermore, this 
study was restricted to a single university, and cannot be generalized across institutions. This 
study did not attempt to identify whether any specific types of minimal risk studies or research 
designs took longer to be approved than others. It must also be acknowledged that the taxonomy 
of acceptable and unacceptable review periods (Table. 3.5.1) was rather arbitrary and could be 
criticised. It was, however, constructed in the absence of any relevant guidance or international 
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